Menezon

Travoprost, the active ingredient in Menezon, is a Prostaglandin F2α analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure by enhancing aqueous humor outflow and is prescribed for patients with glaucoma or ocular hypertension. It is commonly administered once daily in the evening to maintain consistent pressure control.

GNH USA supplies Menezon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

Travoprost is used in the management of ocular conditions that require reduction of intra‑ocular pressure.

Primary open-angle glaucoma: reduces IOP to slow optic nerve damage. Ocular hypertension: lowers pressure to prevent progression to glaucoma. Secondary open-angle glaucoma: helps control pressure when other causes are present.

Travoprost may cause ocular and systemic adverse reactions, which are categorized by frequency.

Common Side Effects: - Eye redness: mild to moderate hyperemia of the conjunctiva. - Eye irritation: burning or stinging sensation after instillation. - Increased eyelash growth: longer, thicker lashes. - Darkening of iris: gradual brown pigmentation change. - Blurred vision: transient visual disturbance.

Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract requiring medical attention. - Macular edema: swelling of the central retina that can affect vision. - Allergic reaction: severe eye swelling, itching, or systemic hypersensitivity.

When prescribing Travoprost, clinicians should consider the following precautions.

Pregnancy: safety not established; avoid use unless benefit outweighs risk. Breastfeeding: unknown excretion in milk; caution advised. Active ocular inflammation: contraindicated in patients with uveitis or ocular infection. Periodic IOP monitoring: assess pressure response after initiation. Contact lens wearers: advise removal before instillation to prevent film buildup. Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Travoprost can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic prostaglandin analogs: additive IOP‑lowering effect may cause hypotony. - Ocular irritants (e.g., anesthetic drops): may increase ocular surface discomfort.

Moderate Interactions (Monitor Closely): - Alpha‑adrenergic agonist eye drops: may reduce overall pressure‑lowering effect. - Carbonic anhydrase inhibitor eye drops: monitor for excessive IOP reduction. - Miotic agents (e.g., pilocarpine): may counteract outflow enhancement.